XPH

SPDR® S&P Pharmaceuticals ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

43.33
0.00
0.00%
Closed 16:00 07/10 EDT
OPEN
43.20
PREV CLOSE
43.33
HIGH
43.50
LOW
42.92
VOLUME
26.08K
TURNOVER
--
52 WEEK HIGH
48.12
52 WEEK LOW
30.30
TOTAL ASSET
245.40M
YTD YIELD
-4.89%
1D
5D
1M
3M
1Y
5Y

XPH News

More
FDA to resume on-site inspections in U.S.
Seeking Alpha - Article · 1d ago
Eli Lilly Q1 Earnings Call Key Takeaways
Seeking Alpha - Article · 04/27 11:22
Sanders' big Nevada primary win shakes health-related stocks
Seeking Alpha - Article · 02/24 15:10
Should Investors Avoid U.S. Healthcare Stocks In An Election Year?
Seeking Alpha - Article · 02/10 14:35
Investing In The Prospect Of Drug Pricing Reforms
Seeking Alpha - Article · 02/06 12:29
Deep-Value ETF Report: Commodities/Energy Remain Out Of Favor
Seeking Alpha - Article · 01/11 13:12
The Trouble With Pharma
Seeking Alpha - Article · 12/31/2019 08:25
GUSH, PALL, VNQI and XOP among weekly ETF movers
Seeking Alpha - Article · 12/22/2019 06:53

Profile

Fund Name
SPDR® S&P Pharmaceuticals ETF
Risk
Medium-high risk
Inception Date
2006-06-19
Benchmark
S&P Pharms Select Industry TR USD*100.0%
Advisor Company
State Street Global Advisors Ltd
Custodian
State Street Bank & Trust Co
Manager
Michael Feehily, Karl Schneider, Keith Richardson

Asset Allocation

251.99M
  • 99.9404%
  • 0.00%
  • 0.0596%
  • 0.00%

2020 Q2

251.99M

2020 Q1

182.87M

2019 Q4

228.83M

2019 Q2

212.69M

2019 Q1

255.84M

Dividend History

Ex-Div Date
Dividend Per Share
06/22/2020
0.0667
03/23/2020
0.0717
12/23/2019
0.0711
09/23/2019
0.0840
06/24/2019
0.0683
More